Status: Recruiting
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
This is a study to investigate the safety and efficacy of an investigational OBX-115 regimen in adult participants with advanced solid tumors.
Participants needed: 208
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Obsidian Therapeutics, Inc.Updated: Jun 29, 2026Locations: 10
Eligibility criteria
Participant must be 18 years of age or older at the time of signing the informed... [+18]
Participant has melanoma of uveal origin or its other genetic equivalents (e.g.... [+10]